Metys Pharmaceuticals

Metys Pharmaceuticals

Verified
Developing dimiracetam for the prevention of chemotherapy-induced painful peripheral neuropathy.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$5—7m (Dealroom.co estimates Oct 2013.)
Company register number CH-270.3.014.848-3
Basel Canton of Basel-Stadt (HQ)
Authorizing premium user...